Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole pretreatment combined with misoprostol for medical abortion
IRCT20220522054961N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole and misoprostol in pregnancy (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Complete abortion rate, Incomplete abortion rate and 5 more. Started Oct 2022; status: completed.
02
Drugs
letrozolemisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on IRCT20220522054961N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220522054961N1.